448 related articles for article (PubMed ID: 17015423)
21. Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.
Machado-Pinilla R; Carrillo J; Manguan-Garcia C; Sastre L; Mentzer A; Gu BW; Mason PJ; Perona R
Clin Transl Oncol; 2012 Oct; 14(10):755-63. PubMed ID: 22855157
[TBL] [Abstract][Full Text] [Related]
22. Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita.
Wong JM; Kyasa MJ; Hutchins L; Collins K
Hum Genet; 2004 Oct; 115(5):448-55. PubMed ID: 15349768
[TBL] [Abstract][Full Text] [Related]
23. Dyskerin, telomerase and the DNA damage response.
Gu B; Bessler M; Mason PJ
Cell Cycle; 2009 Jan; 8(1):6-10. PubMed ID: 19106610
[TBL] [Abstract][Full Text] [Related]
24. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.
Garus A; Autexier C
RNA; 2021 Dec; 27(12):1441-1458. PubMed ID: 34556550
[TBL] [Abstract][Full Text] [Related]
25. N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.
MacNeil DE; Lambert-Lanteigne P; Autexier C
Nucleic Acids Res; 2019 Jun; 47(10):5368-5380. PubMed ID: 30931479
[TBL] [Abstract][Full Text] [Related]
26. Dissecting dyskeratosis.
Meier UT
Nat Genet; 2003 Feb; 33(2):116-7. PubMed ID: 12560816
[No Abstract] [Full Text] [Related]
27. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
Polychronopoulou S; Koutroumba P
Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
[TBL] [Abstract][Full Text] [Related]
28. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
Mason PJ; Wilson DB; Bessler M
Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
[TBL] [Abstract][Full Text] [Related]
29. [Dyskeratosis congenita, a disease caused by defective telomere maintenance].
Hoareau-Aveilla C; Henry Y; Leblanc T
Med Sci (Paris); 2008 Apr; 24(4):390-8. PubMed ID: 18405638
[TBL] [Abstract][Full Text] [Related]
30. Dyskeratosis congenita: a genetic disorder of many faces.
Kirwan M; Dokal I
Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
[TBL] [Abstract][Full Text] [Related]
31. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
[TBL] [Abstract][Full Text] [Related]
32. Engineered telomere degradation models dyskeratosis congenita.
Hockemeyer D; Palm W; Wang RC; Couto SS; de Lange T
Genes Dev; 2008 Jul; 22(13):1773-85. PubMed ID: 18550783
[TBL] [Abstract][Full Text] [Related]
33. Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.
Gourronc FA; Robertson mM; Herrig AK; Lansdorp PM; Goldman FD; Klingelhutz AJ
Exp Dermatol; 2010 Mar; 19(3):279-88. PubMed ID: 19558498
[TBL] [Abstract][Full Text] [Related]
34. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice.
Gu BW; Bessler M; Mason PJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10173-8. PubMed ID: 18626023
[TBL] [Abstract][Full Text] [Related]
35. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.
He H; Wang Y; Guo X; Ramchandani S; Ma J; Shen MF; Garcia DA; Deng Y; Multani AS; You MJ; Chang S
Mol Cell Biol; 2009 Jan; 29(1):229-40. PubMed ID: 18936156
[TBL] [Abstract][Full Text] [Related]
36. Dyskeratosis congenita.
Vulliamy T; Dokal I
Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
[TBL] [Abstract][Full Text] [Related]
37. Dyskeratosis congenita: its link to telomerase and aplastic anaemia.
Dokal I; Vulliamy T
Blood Rev; 2003 Dec; 17(4):217-25. PubMed ID: 14556776
[TBL] [Abstract][Full Text] [Related]
38. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients.
Agarwal S; Loh YH; McLoughlin EM; Huang J; Park IH; Miller JD; Huo H; Okuka M; Dos Reis RM; Loewer S; Ng HH; Keefe DL; Goldman FD; Klingelhutz AJ; Liu L; Daley GQ
Nature; 2010 Mar; 464(7286):292-6. PubMed ID: 20164838
[TBL] [Abstract][Full Text] [Related]
39. Dyskeratosis congenita as a disorder of telomere maintenance.
Nelson ND; Bertuch AA
Mutat Res; 2012 Feb; 730(1-2):43-51. PubMed ID: 21745483
[TBL] [Abstract][Full Text] [Related]
40. A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice.
Frescas D; de Lange T
Genes Dev; 2014 Jan; 28(2):153-66. PubMed ID: 24449270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]